SuperworthSolid Biosciences market cap SLDB
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $634.8M
- Highest close in our data
- $1.8B
- Sep 2018
Solid Biosciences is worth $634.8M at the close on Oct 23, 2026, at $5.92 a share.
That is up 45% over the last year and up 184% over five years.
Its highest close in our data was $1.8B in Sep 2018.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $634.8M | $412.1M | $1.1B | +40% |
| 2025 | $455M | $115.1M | $542.6M | +169% |
| 2024 | $169.4M | $111.6M | $519.2M | +37% |
| 2023 | $123.9M | $31M | $137.4M | +206% |
| 2022 | $40.5M | $40.5M | $174.3M | −79% |
| 2021 | $193M | $186.4M | $575.5M | −58% |
| 2020 | $458.2M | $96.7M | $458.2M | +133% |
| 2019 | $196.8M | $161.4M | $1.1B | −79% |
| 2018 | $921.6M | $672M | $1.8B | n/a |
Against its peers
Companies in Biotechnology nearest Solid Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| SLDBSolid Biosciences | $634.8M |
| MGTXMeiraGTx | $884.6M |
| PLXProtalix BioTherapeutics | $205.5M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Solid Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.